Dipa Talati Mehta
Dipa is a Vice President at Sandbox Industries, a business incubator and venture capital firm that is the fund manager for the BlueCross BlueShield Venture Fund, based in Chicago, Illinois.
Previously, Dipa was at Amgen Ventures, the corporate venture fund of Amgen. At Amgen, Dipa worked closely with the global commercial and marketing organizations to identify companies in the digital health space for their products.
Dipa has always been passionate about the healthcare realm, starting from her research work in high school at Albert Einstein Medical Center. She started her career as an analyst at UBS, in their Global Healthcare Investment Banking group in New York, where she worked primarily with healthcare services companies in providing detailed financial and strategic analysis on financing and acquisitions options. After the end of her two-year analyst program, Dipa joined Paul Capital Partners to work in their healthcare fund. Paul Capital invested in public/private late-stage pharmaceutical and biotechnology companies as well as monetizing royalty streams for inventors, universities and companies.
Education, Personal, and Fellowship
Dipa received her MBA from the University of Chicago Booth School of Business with concentrations in entrepreneurship and finance. She also received a certificate from Graduate Program in Health Administration and Policy, an interdisciplinary program between the medical school, public policy school and school of social work. At Booth, Dipa was a LEAD Facilitator, Admissions Fellow, and Co-chair of the Healthcare Group. She received the Chicago Booth Leadership Award of Distinction given annually to the graduating students who have made outstanding contributions in the areas of leadership, student life, and community service while at Booth.
Dipa completed her undergraduate studies from New York University ? Stern School of Business with majors in finance and CPA accounting.
Dipa is member of Class 17 and served her fellowship at Amgen Ventures under the mentorship of Janis Naeve and Head of Corporate Development & Strategy Dave Piacquad.